J. Schimke

The addition of rituximab to front-line therapy with CHOP (R-CHOP) results in a higher response rate and longer time to treatment failure in patients with lymphoplasmacytic lymphoma: results of a randomized trial of the German Low-Grade Lymphoma Study Group (GLSG)

Christian Buske, Eva Hoster, Martin Dreyling et al. · Leukemia · 2008 · 155 citations

Medicine, Oncology, Immuno-oncology Pharmacotherapy +5

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

Meinolf Karthaus, Harald Balló, W. Abenhardt et al. · Oncology · 2005 · 49 citations

Medicine, Oncology, Pharmacotherapy +17

Palliative treatment of advanced pancreatic carcinoma in community-based oncology group practices.

H. F. Koeppler, Monika Grundheber, Jochen Heymanns et al. · PubMed · 2004 · 11 citations

Medicine, Oncology, Radiation Oncology +17